Segments - Radiosurgery Systems Market by Type (Gamma Knife, Proton Beam Therapy, and Linear Accelerator), Tumor Type (Brain Tumors and Spine Tumors), End-user (Hospitals, Clinics, and Academic & Research Institutes), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global radiosurgery systems market size was USD 2.38 Bn in 2022 and is likely to reach USD 3.99 Bn by 2031, expanding at a CAGR of 6.9 % during 2023–2031. The rising prevalence of cancer and tumor cases is driving the need for radiosurgery systems for better treatment is driving the market
Radiosurgery systems are used in radiosurgery or stereotactic radiosurgery, which is a very accurate form of therapeutic radiology. Treating cancerous tissues in radiosurgery does not include a typical surgery. Targeted beams of radiation are used in place of surgical incisions. Beams of radiation include X-rays, gamma rays, or protons.
Radiosurgery treatment is completed in a single session and it creates similar results as compared to surgery. One example of radiosurgery is tissue destruction performed using ionizing radiation rather than creating excision. It also destroys DNA in tumor cells and prevents its further production.
External radiation therapy is called radiosurgery and it uses special devices to position the patient’s body part to offer a high dose of radiation that can be delivered to the tumor. Radiosurgery treats benign or malignant tumors in conditions including spine & brain tumors and cancer.
According to the National Cancer Institute (NCI) of the US, nearly 50% of cancer patients are treated using radiosurgery. Advanced tumor tracking, robotics, and imaging facilities ease the treatment and surgery for healthcare experts.
The research report finds that the COVID-19 pandemic impacted several industries including the radiosurgery systems market. Surgical centers were modified into COVID-19 hospitals due to the rising number of COVID patients and the lack of treatment facilities. This resulted in the delaying or rescheduling of many radiotherapy treatment cases.
The increasing usage and demand for personal protective equipment (PPE) kits during the pandemic caused a shortage of PPE kits during other surgical processes. These factors affected the market during the pandemic.
The rising spine and brain tumor cases increase the demand for radiosurgery treatment and systems, thus driving the market during the forecast period. Technological developments for cancer care in the health industry increase the demand for treatment.
Rising awareness and curiosity about the devices used to treat arteriovenous malformations, epilepsy, and Parkinson’s disease is further boosting the market. Moreover, rising awareness about minimally invasive radiosurgery and its benefits such as lower mortality, shorter hospital stays, and faster recovery is further fueling the market.
The high cost of surgeries, shortage of reimbursement policies, and lack of infrastructural development are expected to hamper the market in the coming years. Stereotactic radiosurgery causes tiredness or fatigue and affects the healthy tissues as well. This is projected to restrain the market.
Technological advancements in radiosurgery procedures and enhancement in the systems used for stereotactic radiosurgery are anticipated to create lucrative opportunities in the market. Rising cancer cases in developing countries with high population densities require necessary health infrastructure. Additionally, the rising demand for personalized or customized medicines is expected to create new pathways in the market.
Key manufacturers are focusing on installing advanced diagnostics centers for better treatment of patients suffering from cancer and chronic diseases which further creates opportunities for the market in the coming years.
The report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Radiosurgery Systems Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Gamma Knife, Proton Beam Therapy, and Linear Accelerator), Tumor Type (Brain Tumors and Spine Tumors), and End-user (Hospitals, Clinics, and Academic & Research Institutes) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Elekta; Siemens; Accuray Incorporated; Brainlab AG; Medtronic; RefleXion; ZAP Surgical Systems, Inc.; ViewRay Technologies, Inc.; Mevion Medical Systems; and Summit Cancer Centers |
Based on type, the radiosurgery systems market is divided into gamma knife, proton beam therapy, and linear accelerator. The gamma knife segment is expected to expand at a significant growth rate during the projection period, due to the increased adoption of the gamma knife system for treating brain tumors and neurological disorders.
The gamma knife system is a non-invasive radiosurgery system that uses Cobalt-60 systems and radiation beams. These systems and radiations target from around 200 angles converged at a single tumor point. The stereotactic head frame is attached to a patient which gives 3D pictures, further fueling the segment.
The proton beam therapy segment is projected to contribute a considerable market share in the coming years, owing to fewer side effects and the high efficacy of the surgery. The traditional way of cancer treatment is where traditional radiation delivers a beam of photons or digital X-rays to the tumor and beyond. In this case, during the treatment, the radiation damages nearby tissues that are healthy and caused side effects.
On the other hand, proton beam therapy delivers a proton beam that stops at the tumor and does not pass through it , making it a safer cancer treatment than others. This is one of the major factors, doctors are preferring proton beam therapy for cancer treatments as it reduces the risk of side effects and damaging healthy tissues.
On the basis of tumor type, the global market is segregated into brain tumors and spine tumors. The brain tumors segment is projected to register a considerable CAGR during the forecast period, due to the rising prevalence of brain cancer and tumors.
Radiosurgery is widely used to treat patients suffering from cancer, especially ones with brain tumors. This therapy is effective for cancer treatment as it uses strong beams of energy to kill cancer cells and helps in controlling the growth of brain tumor cells. Advancements in healthcare technology and increasing awareness regarding the well-being of the brain are further driving the segment.
The spine tumors segment is anticipated to witness significant growth in the market, owing to the increasing prevalence of spinal cancer. Rising awareness regarding spinal cord care and a surge in the number of experts to operate surgeries for spine tumors is further driving the segment.
On the basis of end-user, the radiosurgery systems market is segmented into hospitals, clinics, and academic & research institutes. The hospitals segment is expected to register a robust growth rate during the forecast period due to the availability of all the advanced medical devices necessary for cancer treatment. The rising number of chronic diseases and growing need for multispecialty hospitals for early diagnosis of cancer and better treatment is expected to boost the segment.
The academic & research institutes segment is expected to grow at a significant growth rate in the coming years due to increasing government activities for research & development and to provide advanced medical devices in research institutes for better results.
In terms of region, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the increasing number of research facilities and rising prevalence of cancer cases in the region. Technological advancements in the healthcare industry and the presence of major players who manufacture radiosurgery systems in the region are further boosting the regional market.
Asia Pacific is projected to contribute significantly to the market growth in the coming years, attributed to the rising government expenditure on developing the healthcare sector in emerging economies. The rising geriatric population with chronic diseases and the increasing prevalence of chronic cancer cases in the region are further fueling the market in the region.
The radiosurgery systems market has been segmented on the basis of
Key players operating in the global radiosurgery systems market include Elekta; Siemens; Accuray Incorporated; Brainlab AG; Medtronic; RefleXion; ZAP Surgical Systems, Inc.; ViewRay Technologies, Inc.; Mevion Medical Systems; and Summit Cancer Centers
These companies adopt strategies such as acquisitions, partnerships, collaboration, R&D investments, mergers, and product launches to boost their market share.